BioSpace News Archive

Biomea Fusion, Inc. (Nasdaq: BMEA), announced the nomination of its second product candidate, BMF-500, a highly selective and potent covalent investigational third-generation FLT3 inhibitor.

Azenta, Inc. announced that Company management will participate in the UBS Global Healthcare Conference in New York, on Tuesday, May 24, 2022, which includes a presentation beginning at 2:45 pm ET.

ALK has appointed Hans Lindeberg as its new Senior Vice President of Commercial Operations in North America.

Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases, and Lonza announced today the opening of a new, custom-built, bioconjugation facility within Lonza’s Ibex® Dedicate manufacturing complex in Visp (CH).

Immunome Announces Data Demonstrating COVID-19 Antibody Cocktail Potently Clears Omicron BA.1 Variant in Hamster Model and Retains Activity Against BA.2 Subvariant.

Adiso Therapeutics’ ADS024 Selected for Oral Presentation at 2022 Digestive Disease Week Annual Meeting.

Age-related diseases account for approximately 70% of all deaths and annually cost the global economy trillions of dollars.

MP Biomedicals, LLC today announced an agreement to distribute the non-prescription home use Boson™ Rapid SARS-CoV-2 Antigen Test Card.

Inversago Pharma Inc. (“Inversago”), a clinical stage biotech company with a unique portfolio of CB1 inverse agonists, announces the presentation of preclinical data at the 59th Congress of the European Renal Association (ERA), the largest annual nephrology meeting in Europe, currently held in Paris, France.

Pulse Biosciences, Inc. (Nasdaq: PLSE) (the “Company” or “Pulse Biosciences”), a novel bioelectric medicine company commercializing the CellFX® System Powered by Nano-Pulse Stimulation™ (NPS™) technology, announced today two changes to its current rights offering.